CORC

浏览/检索结果: 共34条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Circular Bispecific Aptamer-Mediated Artificial Intercellular Recognition for Targeted T Cell Immunotherapy 期刊论文
ACS NANO, 2020, 卷号: 14
作者:  Yang, Yu;  Sun, Xiaoqi;  Xu, Jun;  Cui, Cheng;  Yazd, Hoda Safari
收藏  |  浏览/下载:41/0  |  提交时间:2020/10/26
Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma 期刊论文
CANCER MEDICINE, 2019, 卷号: 8, 期号: 11
作者:  Li, Tianjiao;  Li, Hao;  Li, Shuo;  Xu, Shuaishuai;  Zhang, Wuhu
收藏  |  浏览/下载:15/0  |  提交时间:2019/12/05
Efficiency of CAR-T Therapy for Treatment of Solid Tumor in Clinical Trials: A Meta-Analysis 期刊论文
DISEASE MARKERS, 2019
作者:  Hou, Bin;  Tang, Yao;  Li, Wenhan;  Zeng, Qingnuo;  Chang, Dongmin
收藏  |  浏览/下载:8/0  |  提交时间:2019/11/19
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia 期刊论文
2019
作者:  Pan Jing
收藏  |  浏览/下载:33/0  |  提交时间:2020/01/03
The landscape of CAR T-cell therapy in the United States and China: A comparative analysis 期刊论文
2019, 卷号: 144, 期号: 8, 页码: 2043-2050
作者:  Gou, Lijuan;  Gao, Jianchao;  Yang, Huan;  Gao, Chenyan
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC 期刊论文
Aging-Us, 2019, 卷号: 11, 期号: 23, 页码: 11054-11072
作者:  Y.Liu;  Y.H.Zhou;  K.H.Huang;  Y.Li;  X.J.Fang
收藏  |  浏览/下载:2/0  |  提交时间:2020/08/24
Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy 期刊论文
Journal of Immunotherapy, 2018
作者:  Yi Zhang;  Jianmin Huang;  Ying Zeng;  Hongling Zhang;  Yingjin Qiao
收藏  |  浏览/下载:71/0  |  提交时间:2019/01/31
TARGETING HYPOXIA DOWNSTREAM SIGNALING PROTEIN, CAIX FOR CAR-T CELL THERAPY AGAINST GLIOBLASTOMA (GBM) 会议论文
作者:  Cui, Jing;  Zhang, Qi;  Song, Qi;  Wang, Herui;  Cao, Xiaoyu
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Engineering chimeric antigen receptor-T cells for cancer treatment 期刊论文
Molecular Cancer, 2018, 卷号: 17, 期号: 1, 页码: 32
作者:  Ye, Baixin;  Stary, Creed M.;  Li, Xuejun;  Gao, Qingping;  Kang, Chunsheng*
收藏  |  浏览/下载:17/0  |  提交时间:2019/12/03
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 卷号: 11
作者:  Zhao, Wan-Hong;  Liu, Jie;  Wang, Bai-Yan;  Chen, Yin-Xia;  Cao, Xing-Mei
收藏  |  浏览/下载:3/0  |  提交时间:2019/11/26


©版权所有 ©2017 CSpace - Powered by CSpace